Grant: Operating Grant - PA: Gender, Sex and Health Research
University of Toronto
$100,000.00
Advancing New Prevention Technologies for HIV: Rectal Microbicide Acceptability among Men who have Sex with Men and Transgenders in India and Thailand
FY 2010-11
Summary
With over 30 million people living with HIV worldwide, and 7,400 new HIV infections every day, new prevention technologies are our greatest hope for reversing the global AIDS epidemic. Microbicides are among the most promising products under development. A microbicide to reduce HIV transmission during vaginal or anal intercourse could take many forms, including a gel, cream or douche. In particular, a rectal microbicide would be an important addition to HIV prevention methods for men who have sex with men (MSM) and transgender women, who are at disproportionately high risk for HIV globally. A growing epidemic among MSM in Asia has been largely neglected; in Thailand, MSM are 20-30 times more likely to contract HIV than the general population. Nevertheless, the development of a rectal microbicide is not sufficient: it is vital to conduct social and behavioral research to prepare for future microbicides. Understanding the preferences and concerns of people who a product is intended for is an important way to ensure the product will be used. This innovative study is the first to investigate the acceptability of microbicides among MSM and transgender women in Asia, with a focus on Thailand. By integrating advanced qualitative and quantitative approaches, the study will provide vital information on key factors at the individual and social level that help to determine future microbicide use among MSM and transgender women. Results will be shared with local communities, healthcare providers, policymakers, Canadian and international advocacy organizations, and basic scientists in Canada, Thailand and globally. As HIV ultimately knows no borders, and the costs to Canada amount to millions of dollars annually to pay for expensive HIV treatments for Canadians and people from developing countries, our investment in social research on new prevention technologies is both an ethical and cost-effective response to reverse the most deadly epidemic of our time.
Department
Program
Operating Grant - PA: Gender, Sex and Health Research
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
215403
Name
Newman Peter A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Gender, Sex & Health
Projecttitle
Advancing New Prevention Technologies for HIV: Rectal Microbicide Acceptability among Men who have Sex with Men and Transgenders in India and Thailand
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Gender, Sex and Health Research
Keyworddelim
Consumer Preference; Discrete Choice Analysis; Hiv/Aids; Men Who Have Sex With Men; Microbicides; Mixed Methods Research; Rectal Microbicide Acceptability; Sexual Risk Behaviors; Thailand; Transgender Women
Abstract
With over 30 million people living with HIV worldwide, and 7,400 new HIV infections every day, new prevention technologies are our greatest hope for reversing the global AIDS epidemic. Microbicides are among the most promising products under development. A microbicide to reduce HIV transmission during vaginal or anal intercourse could take many forms, including a gel, cream or douche. In particular, a rectal microbicide would be an important addition to HIV prevention methods for men who have sex with men (MSM) and transgender women, who are at disproportionately high risk for HIV globally. A growing epidemic among MSM in Asia has been largely neglected; in Thailand, MSM are 20-30 times more likely to contract HIV than the general population. Nevertheless, the development of a rectal microbicide is not sufficient: it is vital to conduct social and behavioral research to prepare for future microbicides. Understanding the preferences and concerns of people who a product is intended for is an important way to ensure the product will be used. This innovative study is the first to investigate the acceptability of microbicides among MSM and transgender women in Asia, with a focus on Thailand. By integrating advanced qualitative and quantitative approaches, the study will provide vital information on key factors at the individual and social level that help to determine future microbicide use among MSM and transgender women. Results will be shared with local communities, healthcare providers, policymakers, Canadian and international advocacy organizations, and basic scientists in Canada, Thailand and globally. As HIV ultimately knows no borders, and the costs to Canada amount to millions of dollars annually to pay for expensive HIV treatments for Canadians and people from developing countries, our investment in social research on new prevention technologies is both an ethical and cost-effective response to reverse the most deadly epidemic of our time.
Competitiondate
201009
Approvedterm2
1 yr 0 mth
Pinamesdelim
Newman, Peter A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~